Using blood tests and imaging to improve immunotherapy for lung cancer
Integrated blood and radiomic subtyping to guide immunotherapy treatment selection and early response assessment in metastatic non-small cell lung cancer
This study is looking at how using blood tests and imaging together can help doctors find the best immunotherapy treatments for people with advanced lung cancer, making it easier and less invasive for patients to get personalized care that works better for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10862751 on NIH RePORTER |
What this research studies
This research investigates how combining blood tests and imaging can help doctors choose the best immunotherapy treatments for patients with metastatic non-small cell lung cancer (NSCLC). By analyzing blood samples and radiomic data, the study aims to create personalized treatment plans that can better predict how patients will respond to therapy. The approach focuses on developing new tools that are less invasive than traditional tissue biopsies, making it easier for patients to participate in their treatment planning. Ultimately, the goal is to enhance the effectiveness of immunotherapy and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with metastatic non-small cell lung cancer who are considering immunotherapy options.
Not a fit: Patients with early-stage lung cancer or those not eligible for immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized immunotherapy treatments for lung cancer patients.
How similar studies have performed: Previous research has shown promise in using blood and imaging techniques for cancer treatment personalization, indicating a potential for success in this novel approach.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Vokes, Natalie — University of Tx Md Anderson Can Ctr
- Study coordinator: Vokes, Natalie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.